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Abstract1
Recent studies suggest that context-specific eQTLs underlie genetic risk factors for complex diseases.2
However, methods for identifying them are still nascent, limiting their comprehensive characteriza-3
tion and downstream interpretation of disease-associated variants. Here, we introduce FastGxC, a4
method to efficiently and powerfully map context-specific eQTLs by leveraging the correlation struc-5
ture of multi-context studies. We first show via simulations that FastGxC is orders of magnitude6
more powerful and computationally efficient than previous approaches, making previously year-7
long computations possible in minutes. We next apply FastGxC to bulk multi-tissue and single-cell8
RNA-seq data sets to produce the most comprehensive tissue- and cell-type-specific eQTL maps9
to date. We then validate these maps by establishing that context-specific eQTLs are enriched10
in corresponding functional genomic annotations. Finally, we examine the relationship between11
context-specific eQTLs and human disease and show that FastGxC context-specific eQTLs provide12
a three-fold increase in precision to identify relevant tissues and cell types for GWAS variants than13
standard eQTLs. In summary, FastGxC enables the construction of context-specific eQTL maps14
that can be used to understand the context-specific gene regulatory mechanisms underlying complex15
human diseases.16
1 Introduction17
Genetic variants associated with complex disease reside mainly in the non-coding component of18
the genome, leading to the natural hypothesis that they act through transcriptional regulation19
[1]. Large-scale multi-context expression quantitative trait loci (eQTL) studies have demonstrated20
extensive sharing of eQTL effects across contexts, such as tissues and cell types [2–5], environmental21
stimulation [6], advanced aging [7], etc. For example, characterization of cis eQTLs across 4922
human tissues in the Genotype-Tissue Expression (GTEx) project has revealed cis eQTLs for 95%23
of protein-coding genes in at least one tissue [2, 3] and sharing of 85% of eQTLs across tissues [5].24
This pervasive sharing complicates the mechanistic understanding of complex trait associations and25
prioritization of the disease-relevant contexts for eQTLs.26
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Interestingly, eQTLs often exhibit complex patterns of context-specific effects, wherein a vari-27
ant can regulate, to a different degree, the expression of a gene across many contexts [5]. Charac-28
terization of these variants will allow a better understanding of gene regulation and disease etiology.29
Indeed, mounting evidence suggests that genetic variants underlying disease associations are often30
context-specific [8–16]. For example, the Immune Variation project identified eQTLs in monocyte-31
derived dendritic cells and human CD4+ T lymphocytes with different effects in response to in vitro32
stimulation and polarization [13, 17]. These previously unknown, immune state-specific eQTLs33
strongly overlapped autoimmune disease-associated variants [6, 18, 19]. Similarly, [20] mapped34
eQTLs during differentiation of induced pluripotent stem cells to cardiomyocytes to identify eQTLs35
that change over time. These dynamic eQTLs were enriched for genes with roles in myogenesis and36
dilated cardiomyopathy.37
To identify context-specific eQTLs (sp-eQTLs) while constraining experimental heterogeneity38
and reducing costs, studies often gather multiple samples across contexts for the same donors [3,39
17, 21, 22]. Linear mixed models (LMMs) are a natural analysis choice for such studies [23–25]40
because they model the intra-individual correlation inherent across repeated samples and directly41
identify sp-eQTLs by testing for the significance of the genotype-by-context (GxC) interaction term.42
However, these LMMs are computationally infeasible for eQTL studies. Hence, researchers instead43
rely on simple linear models with a GxC (LM-GxC) term [9, 20] or context-by-context (CxC) eQTL44
mapping, followed by post hoc examination of summary statistics to distinguish shared and context-45
specific eQTL effects [2, 3]. While relatively fast, these approaches are significantly underpowered46
because they do not leverage intra-individual correlation in multi-context studies like GTEx (Figure47
S2) and single-cell RNA-Seq data [26]. Additionally, many rely on downstream, ad hoc definitions of48
context-specific and shared genetic effects that are based on subjective, manually selected thresholds49
of effect size differences between contexts [5] or presence-absence of effects in different contexts [3, 8,50
27, 28]. These definitions can have a large impact on context-specific eQTL mapping by under- or51
over-counting sharing of effects across contexts. These shortcomings have limited characterization52
of sp-eQTLs and downstream interpretation of disease-associated variants.53
To address these limitations, we introduce FastGxC, a novel method that leverages the corre-54
lation structure of multi-context studies to efficiently and powerfully map sp-eQTLs. In brief, Fast-55
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GxC decomposes the phenotype of interest per individual into context-shared and context-specific56
components and estimates genetic effects on these factors separately using simple linear models. We57
prove through analytical derivation and empirical examination that FastGxC shared and context-58
specific effect size estimates are a reparametrization of the CxC and LMM-GxC estimates. FastGxC59
has several key advantages over previous methods. First, by removing the intra-individual correla-60
tion, it naturally adjusts for background noise unrelated to the context of interest, e.g., sex, age,61
and sequencing batch [7, 29, 30]. Second, it uses ultra-fast implementations of linear regression62
models specifically designed for eQTL mapping [31]. Third, it directly maps sp-eQTLs without the63
need for post hoc analyses or arbitrary thresholds. Fourth, it provides both global and marginal64
tests for sp-eQTLs. The global test identifies variants with eQTL effect size heterogeneity across65
contexts while the marginal tests identify the context(s) driving this heterogeneity. FastGxC output66
integrates naturally with recent methods developed to improve the statistical power of CxC eQTL67
mapping, such as mash [5], sn spMF [4], and Meta-Tissue [32, 33]. FastGxC is broadly generalizable68
to any continuous phenotype, e.g., bulk or single-cell gene expression [3, 34], protein and metabolic69
measurements [21, 22], and DNA methylation levels [35], measured across different contexts, e.g.,70
tissues and cell types [36–38], environmental perturbations [17, 19], developmental stage [35], aging,71
[7, 22], and differentiation state [20].72
We first show in simulations that FastGxC is as powerful as the LMM-GxC but orders of73
magnitude faster. Both approaches are orders of magnitude more powerful than a heterogeneity74
test based on CxC estimates and LM-GxC in the presence of intra-individual correlation. We next75
applied FastGxC to multi-tissue RNA-Seq data from the GTEx Consortium [3] and peripheral76
blood single-cell RNA-Seq data from CLUES, an in-house 234 person cohort (see accompanying77
manuscript), to produce the most comprehensive tissue- and cell-type-specific eQTL map to date78
across 49 tissues and eight peripheral blood cell types. We validate these maps by establishing79
enrichment of sp-eQTLs in corresponding functional genomic annotations. Finally, we examine80
the relationship between FastGxC sp-eQTLs and human disease and show that they provide a81
three-fold increase in precision to identify relevant contexts for GWAS variants across 138 complex82
traits compared to standard eQTLs. In summary, FastGxC enables the construction of context-83
specific eQTL maps that can be used to understand the context-specific gene regulatory mechanisms84
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underlying complex human diseases.85
2 Results86
FastGxC method overview. We illustrate FastGxC using tissues as the contexts (Figure 1A)87
but the method can be applied to different contexts, e.g., cell types and environmental stimuli.88
Briefly, for each individual, FastGxC decomposes the gene expression across C contexts into one89
context-shared component and C context-specific components (Figure 1A - Decomposition step).90
Next, FastGxC identifies contexts-shared and contexts-specific eQTLs (sh-eQTL and sp-eQTL) by91
estimating genetic effects on the context-shared expression component and each of the contexts-92
specific components (Figure 1A - eQTL mapping step). FastGxC then performs a global test93
for context-specific eQTLs which identifies variants with significant eQTL effect size heterogeneity94
across contexts. Last, to identify the context(s) driving this heterogeneity, FastGxC performs C95
marginal tests for the significance of each of the context-specific eQTLs.96
More formally, let Eic be the observed expression of a gene for individual i (i = 1, . . . , I)97
in context c (c = 1, . . . , C). FastGxC first decomposes Eic into an offset term, a context-shared98
component, and a context-specific component [39], i.e.99
Eic = E.. + (Ei. − E..)︸ ︷︷ ︸
Eshi









/ (I × C) is the average expression of the gene, computed over101




/C is the average expression of the gene102
for individual i, computed over all contexts. In (1), E.. is a term that is constant across individuals103
and contexts for each gene, Eshi is the context-shared expression component for individual i and is104
constant across contexts for each gene and individual, and Etsic is the context-c-specific expression105
component for individual i.106
Next, FastGxC estimates one shared and C context-specific cis genetic effects by regressing107
the genotypes on each component using ultra fast implementations of fixed-effect linear regression108
models [31], i.e.,109
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Eshi = α


















where αsh, αts1 , . . . , α
ts
C are offsets. Gi is the genotype of individual i, coded as number of minor114
alleles, and βsh, βts1 , . . . , β
ts
C are the genetic effects on the shared and each of the context-specific115
expression components. Finally, εtsi1, ε
ts
i1, . . . , ε
ts
iC are each normally distributed residual errors with116
mean zero and variances σ2sh, σ
2
ts,1, . . . , σ
2
ts,C .117
FastGxC defines a shared-eQTL (sh-eQTL) as a variant with a statistically significant effect on118
the shared component, i.e. βsh, and a context-specific eQTL (sp-eQTL) as a variant with at least one119
statistically significant genetic effect on the context-specific expression components, i.e. βts1 , . . . , β
ts
C .120
The later test is performed using Simes’s procedure [40]. In addition, FastGxC defines a sp-eQTL in121
context c as a variant with a statistically significant genetic effect on the context-c-specific expression122
component. Figure 1B illustrates different patterns of sh-eQTL and sp-eQTL effects. Notably,123
FastGxC shared and context-specific eQTL effect size estimates are a reparametrization of the124
CxC and L(M)M-GxC estimates (S3E). Full details of the analytical derivation and relationship to125
previous approaches are provided in the Methods and Supplementary Text.126
FastGxC is more powerful and orders of magnitude faster than existing methods in127
simulation studies. We evaluate the global and marginal type I error rates and power of FastGxC128
in a series of simulations and compare its performance to a CxC-based test of eQTL effect size129
heterogeneity and the LM-GxC and LMM-GxC approaches. In order to obtain global estimates of130
type I error rate and power for each method, we test the global null hypothesis of no heterogeneity131
of genetic effects across contexts. Specifically, for the CxC-based approach, we fit a linear model for132
each context c (Eic = αc + βcGi + εic), and test the null hypothesis of no eQTL effect heterogeneity133
across contexts (H0 : β1 = . . . = βC = 0) using the heterogeneity statistic Q from a random-134
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effects meta-analysis as implemented in the meta R package [41]. For the LM-GxC approach, we135
fit one linear model with a genotype-by-context interaction term (Eic = α + β1Gi +
∑C
c=2 γcKic +136 ∑C
c=2 δcGi × Kic + εic) and test the null hypothesis of no genotype-by-context interaction effects137
(H0 : δ2 = . . . = δC = 0) using the likelihood ratio test. For the LMM-GxC approach, we fit one138
linear random effects model with a genotype-by-context interaction term (Eic = ui + α + β1Gi +139 ∑C
c=2 γcKic +
∑C
c=2 δcGi×Kic +εic ui ∼ N(0, σ2i )) and test the same null hypothesis as the LM-GxE140
model. Finally, for FastGxC, we test the presence of at least one context-specific effect using Simes’s141
method for combining p-values [40]. To assess the ability of FastGxC to identify the heterogeneous142
context(s), we also obtain marginal estimates of type I error rate and power within each context.143
We simulate 10,000 data sets for each scenario. We assume that, in each scenario, gene ex-144
pression is measured in five contexts for 100 individuals. In each scenario, we vary the amount of145
intra-individual correlation, i.e. correlation of gene expression across contexts within individuals,146
from zero, i.e. no intra-individual correlation, to 0.8, i.e. high intra-individual correlation. We147
set the mean of the gene expression in each context to one. Genotypes for each individual were148
simulated using a binomial distribution with a minor allele frequency of 0.2. Under the null hy-149
pothesis of no genetic effect heterogeneity, the effect of the genotype is the same in each context150
(similar to toy example illustrated in Figure 1B - second panel), i.e., βj = 0.1 for j = 1 : 5. We151
simulated two scenarios under the alternative hypothesis of genetic effect heterogeneity. In the first152
scenario (“single-context heterogeneity”), one context had different genetic effects from the other153
four contexts (Figure 1B - third panel), i.e., β1 = β2 = β3 = β4 = 0.1 and β5 = 0.4, and in the154
second scenario (“extensive heterogeneity”), every context had a different genetic effect from all155
other contexts (Figure 1B - fourth panel), i.e., βj = 0.j for j = 1 : 5.156
Under the null hypothesis of no genetic effect heterogeneity, FastGxC and LMM-GxC maintain157
a 5% type I error rate both at the global (Figure 2A) and marginal (Figure S3A) level, regardless of158
the amount of intra-individual correlation. As expected, the CxC-based and LM-GxC approaches,159
which do not model the intra-individual correlation, become more conservative with increasing160
intra-individual correlation (Figure 2A). Under the alternative hypotheses of genetic effect hetero-161
geneity, FastGxC is as powerful as LMM-GxC in both the single-context (Figure 2B) and extensive162
heterogeneity (Figure S3B) scenarios, and both methods become more powerful as the level of intra-163
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted June 18, 2021. ; https://doi.org/10.1101/2021.06.17.448889doi: bioRxiv preprint 
8
individual correlation increases. As expected from their performance under the null scenario, the164
CxC and LM-GxC approaches lose power in the presence of intra-individual correlation (Figures165
2B and S3B). In addition, FastGxC correctly identified the context(s) that drive the heterogeneity166
in both the single-context (Figure 2C) and extensive heterogeneity (Figure S3C) scenarios.167
To benchmark the computational costs of running FastGxC compared to the other approaches,168
we simulated phenotype and genotype data as above. To obtain practical run-times, we used169
study parameters from GTEx, the largest multi-context eQTL study to-date with approximately170
50 contexts and an average of 250 individuals per context, while varying the number of tests171
performed (Figure 2D). When extrapolated to mapping cis-eQTLs in the entire GTEx dataset,172
i.e. approximately 200M tests for 25K genes and 3M SNPs, we found that LMM-GxC and LM-173
GxC would finish in approximately 30 years and 10 months, respectively, while CxC and FastGxC174
achieved equivalent results in under one minute (average run time in 100 iterations). At 1,000175
individuals, FastGxC continues to be efficient (five minutes for all tests) while LMM-GxC would176
take upwards of 500 years (Figure S3D).177
FastGxC produces a high-resolution map of tissue-specific and tissue-shared eQTLs in178
GTEx. We applied FastGxC to GTEx v8 RNA-seq data [3] to decompose the expression in each179
tissue into a tissue-shared and 49 tissue-specific components. To assess the ability of FastGxC to180
remove gene expression background noise, we correlated technical and biological covariates with the181
first ten principal components (PCs) from the original gene expression data and the decomposed182
tissue-shared and tissue-specific expression data (Figure 3A). As expected, the largest sources of183
variation in the original gene expression data, as captured by the top 10 PCs, were highly correlated184
to biological and technical variables such as donor sex, age, ethnicity, and cohort [7, 30, 42]. The185
impact of many of these sources of variation is absent in the FastGxC tissue-specific expression186
components, i.e., the top ten PCs from the tissue-specific expression are not correlated to variables187
that do not change within an individual, e.g. sex, age, and genotype PCs. These results suggest188
that FastGxC effectively reduces background noise inherent in gene expression data by removing189
the intra-individual correlation between tissues transcriptomes from the same individual.190
We next mapped cis eQTLs on each of these components, providing a high resolution map191
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of tissue-shared and tissue-specific eQTLs (sh-eQTLs and sp-eQTLs) (Table S1). We discovered a192
total of 20,947 sh-eGenes, i.e. genes with at least one sh-eQTL (60.7% of tested genes; hierarchical193
FDR (hFDR) ≤ 5%) and an average of 1,620 sp-eGenes, i.e., genes with at least one sp-eQTL, per194
tissue ( 6% tested genes; hFDR ≤ 5%). In addition, we discovered 7,671,697 sh-eQTLs and between195
9,998 (kidney cortex) and 1,008,063 (testis) sp-eQTLs within each tissue, totaling 11,656,197 sp-196
eQTLs across 49 tissues (Figure 3B and S1; hFDR ≤ 5%). Compared to the standard CxC analysis,197
FastGxC discovered an additional 700 eGenes, consistent with the power increase observed in the198
simulations (Figure S4A). Of these additional FastGxC discoveries, 60% are sh-eGenes and the199
remaining 40% are sp-eGenes.200
We then sought to understand the sharing and specificity of FastGxC-mapped eQTLs. We201
found that the majority of sp-eQTLs are discovered in only a few tissues indicating that, for the202
majority of sp-eQTLs, few tissues drive the heterogeneity (Figure 3C). In addition, sp-eQTLs found203
in more biologically-distinct tissues such as testis (16%), make up the largest proportion of the204
sp-eQTLs that are unique to a single tissue (Figure 3C). Across tissues, most variants (85.9-97.5%)205
with tissue-specific eQTL effects have also shared eQTL effects (Figure 3D and S5), suggesting that206
most tissue-specific effects manifest within the shared effect loci and would be missed by approaches207
that define context-specificity by presence or absence of significant eQTL effects in each context208
rather than differences in sizes of eQTL effects.209
Additionally, we show that sp-eQTL effect sizes are correlated between groups of biologically210
related tissues, e.g., sp-eQTL are shared among 13 brain, two heart (left ventricular and atrial ap-211
pendage), two artery (tibial and aorta), two esophagus (muscularis and gastro-esophageal junction),212
three adipose (visceral, subcutaneous, and breast), and two intestine tissues (Figure 4 - right trian-213
gle). This result is consistent with the previously reported high correlation of eQTL effects between214
groups of biologically related tissues from the CxC approach [5]. Yet, while FastGxC sp-eQTL215
effect sizes show little to no correlation outside groups of biologically related tissues, CxC effect216
sizes show widespread correlation across all tissues regardless of biological relationships (Figure 4217
- left triangle). This again demonstrates that FastGxC is able to disentangle tissue specific effects218
from shared effects.219
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Tissue-specific eQTLs are enriched in functional genomic features from their matched220
tissues. To validate FastGxC sh-eQTL and sp-eQTLs and understand the functional differences221
between variants with sh-eQTL and sp-eQTL effects, we performed enrichment analysis for genomic222
elements using variants with sp-eQTL but no sh-eQTL effects (“sp-eQTL only”) and variants with223
sh-eQTL but no sp-eQTL effects (“sh-eQTL only”), compared to a random subset of minor allele224
frequency (MAF)-matched non-eQTL variants (Figure 5A). Sp-eQTL only variants are enriched225
(OR=1.06, p-value = 1.16 × 10−5) while sh-eQTL only variants are depleted (OR=0.98, p-value226
= 2.87 × 10−2) within enhancers (FDR ≤ 5%; Figure 5A). In addition, sh-eQTL only variants227
show stronger enrichment within promoters, compared to sp-eQTL only variants (ORsh = 1.14228
versus ORts = 1.04; p-value = 3 × 10−7). These results are consistent with previous observations229
that variants with tissue-specific effects are more enriched in genomic elements that confer tissue230
specificity to gene expression, such as enhancers, while variants with tissue-shared effects are more231
common within promoters [43].232
In order to understand how eQTL variants mapped by the CxC approach are functionally233
different than FastGxC eQTL variants, we performed enrichment analysis for genomic elements234
using variants that are only discovered by CxC (“CxC only”) or FastGxC (“FastGxC only”) (Figure235
5A). Compared to CxC only variants, the FastGxC-only variants are significantly enriched (FDR236
≤ 5%) in more genomic features and often more strongly enriched in key genomic elements such237
as promoter-flanking regions (ORFastGxC = 1.16 versus ORCxC = 1.08; p-value for OR difference=238
6.4× 10−9) and introns (ORFastGxC = 1.05 versus ORCxC = 1; p-value= 2.3× 10−10). Additionally,239
FastGxC only eQTLs are significantly enriched in enhancers (OR=1.05, p-value = 2.1×10−3), while240
CxC only eQTLs are not (OR=1.02, p-value = 1.8 × 10−1). These results suggested that eQTLs241
only discovered by FastGxC and not CxC are more likely to reside in functional regions.242
As chromatin and TF-binding architectures are strongly tissue-specific [44], they serve as243
important avenues to validate FastGxC mapped sp-eQTLs and quantify the functional differences244
between eQTLs mapped by FastGxC and CxC. We performed enrichment analysis of variants with245
FastGxC sp-eQTL and CxC eQTL effects in a single tissue in open chromatin of several ENCODE246
tissues. Of the 54 pairs of correctly-matched tissues, FastGxC single-tissue sp-eQTL variants are247
enriched in their matched ENCODE tissue more often than CxC single-tissue eQTL variants, i.e.248
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54% (29/54) versus 30% (16/54) of the time (McNemar test, p-value = 1.95 × 10−3; Figure 5B).249
FastGxC variants are also, on average, more strongly enriched in their matched open-chromatin250
regions, compared to CxC variants (ORFastGxC = 1.37 versus ORCxC = 1.18 average across matched251
tissues; Paired t-test, p-value = 9.17× 10−5). Furthermore, we observed widespread enrichment in252
open chromatin for FastGxC and CxC variants with eQTL effects specific to tissues with cell-types253
ubiquitously found across human tissues, e.g. skeletal muscle, breast, and whole blood [45, 46].254
We next performed enrichment analysis of the same sets of variants as above in the predicted,255
tissue-specific TF binding sites (TFBS) [47] (Figure 5C). In line with results from the chromatin256
accessibility data, FastGxC single-tissue sp-eQTL variants are more often enriched in their matched257
tissue-specific TFBS than CxC single-tissue variants, i.e. 53% (16/30) versus 17% (5/30) of the time,258
respectively (McNemar test, p-value = 2.6 × 10−3; Figure 5C). In addition, FastGxC single-tissue259
sp-eQTL variants are, on average, more strongly enriched compared to CxC (ORFastGxC = 1.53260
versus ORCxC = 1.28 average across matched tissues; Paired t-test, p-value = 1.5× 10−3).261
Together these results demonstrate that the tissue-specific components better capture the262
underlying molecular contexts - both tissue-specific chromatin accessibility and TF binding sites -263
of their matched tissues than the CxC approach.264
FastGxC uncovers novel and biologically relevant eQTLs that enhance our understand-265
ing of how genetic effects are shared and divergent across tissues. To provide insight into266
patterns of sharing and specificity of eQTL effects revealed by FastGxC, we discuss a few individual267
examples (Figure 6).268
First, we examine CBS, a gene which encodes the enzyme cystathionine beta-synthase that269
catalyzes the rate-limiting step of the transsulfuration pathway [48, 49] (Figure 6A). This pathway270
acts ubiquitously across many cell-types to perform diverse and important biological functions271
such as protein synthesis and methylation [50]. Indeed, eQTL effect size estimates from CxC are272
significant in 48 individual tissues (hFDR ≤ 5%), suggesting a universal, shared mechanism of273
genetic regulation. FastGxC crystallizes this shared mechanism by identifying a single sh-eQTL274
and no sp-eQTLs (hFDR ≤ 5%).275
Second, we show an eQTL for SIGLEC14, an immune cell surface receptor of the immunoglob-276
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ulin superfamily involved in the innate immune response [51] (Figure 6B). Similar to the CBS ex-277
ample, there seems to be a sharing of genetic effects across GTEx tissues which could lead one to278
conclude that this genetic effect is invariant across the body. Yet, when we explicitly model this279
sharing with FastGxC, a sp-eQTL effect in whole blood emerges, indicating that, while SIGLEC14280
is under a universal tissue-shared genetic regulation, there is importantly also a blood-specific reg-281
ulatory mechanism that is consistent with the known role of SIGLEC14 in immunity.282
Finally, we discuss the genetic regulation of LDHC, which encodes the testis-specific enzyme283
lactate dehydrogenase C, the first testis-specific enzyme discovered in male germ cells [52] (Figure284
6C). We found that LDHC exhibits a strong positive eQTL effect in all tissues except the testis for285
which the eQTL effect is in the opposite direction. This lone effect becomes very apparent when286
sp-eQTLs are examined with FastGxC. To the best of our knowledge, this is the first time that287
testis-specific genetic regulation, in addition to testis-specific expression, is reported for this gene,288
suggesting that tissue-specificity can be regulated at multiple biological levels.289
We present additional examples that illustrate the power of FastGxC to map context-specific290
eQTL effects in Figure S6.291
Tissue-specific eQTLs identify putatively causal tissues of complex traits. One of the292
primary goals for mapping QTLs is to find the molecular link between genetic variants and their293
associated diseases. As such, we next explored whether FastGxC results can lead to better under-294
standing of the regulatory mechanisms and contexts in which these mechanisms operate in complex295
human diseases. Specifically, we extracted an independent set of trait-associated variants from 138296
mapped traits in the NHGRI-EBI GWAS catalog [53]. We followed the protocol of the GTEx con-297
sortium and used expert curation to identify the most likely relevant tissue(s) (Table S2) [3]. We298
tested FastGxC sh-eQTL and sp-eQTL variants for enrichment in these sets, compared to a random299
and equal sized set of MAF-matched non-eQTL variants. We compare these enrichment results to300
ones based on variants with standard CxC eQTL effects in each tissue (Table S2).301
FastGxC sh-eQTL and sp-eQTLs provide a three-fold increase in precision to identify the302
disease-relevant tissue(s) and a two-fold improvement in their rank compared to standard CxC303
eQTLs (Figure 7A). In addition, CxC eQTLs prioritize 22 of the 49 tissues tested per trait (me-304
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dian across traits), likely due to the large amount of tissue-sharing of CxC eQTL effects (Figure305
4). By contrast, FastGxC prioritizes only five tissues per trait with a similar recall rate as CxC.306
This difference suggests that modeling the extensive sharing of eQTL effects across tissues has the307
potential to improve our ability to localize GWAS associations to a smaller subset of putatively308
causal tissues.309
Across the board, the FastGxC enrichment patterns recapitulate known trait-tissues associ-310
ations (Figure 7B, hFDR≤ 5%). For example, in breast carcinoma, the tissue with the highest311
enrichment according to FastGxC is breast mammary tissue (OR = 5.0, P-value = 3.2 × 10−4).312
On the other hand, for standard eQTLs mapped by CxC, the strongest enrichment was for EBV-313
transformed lymphocytes while breast mammary tissue (OR = 2.24, p-value = 7.5× 10−4) was the314
25th most enriched tissue. In lung adenocarcinoma, the most common type of lung cancer, CxC315
finds significant associations in 22 tissues, many seemingly unrelated to lung physiology (lung OR316
= 2.83, 18th strongest enrichment of 22 tissues, p-value = 1.6×10−3), while FastGxC only finds sig-317
nificant associations in lung (OR = 5.67, p-value = 2.6×10−3) and nerve tibial (OR = 20, p-value =318
2.1× 10−5). Interestingly, in the non tissue-specific cancer trait, we found that for FastGxC shared319
eQTLs showed the strongest enrichment, consistent with the idea that this trait reflects shared320
process across all tissues. This improved tissue resolution was also seen in non-cancer traits. For321
example, in coronary artery disease, CxC finds significant associations in 43 of the 49 tested tissues,322
while FastGxC finds only 16 and the top tissues are almost all cardiovascular-relevant, i.e. coronary323
and aortic artery, heart left ventricle and atrial appendage, skin, muscle, and average tissue.324
Taken together, we demonstrate that FastGxC leads to improved resolution for localizing325
known tissue-trait associations. This result suggests that utilizing FastGxC to map context-specific326
eQTLs has the potential to discover novel links between contexts and diseases, and critically generate327
testable hypothesis for downstream experimental validation.328
Cell-type-specific eQTLs are enriched for variants associated with immune-related com-329
plex traits. Single-cell RNA-seq eQTL studies provide an ideal setting for the application of330
FastGxC because the same donor contributes cells across almost all known cell types, leading to331
considerable intra-individual correlation (Figure 5A of accompanying manuscript). In addition, for332
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cases in which eQTLs from a complex tissue, e.g. whole blood, are enriched for disease-associated333
variants, single cell data provide an opportunity to examine the underlying cell types from this334
complex mixture. To that end, we applied FastGxC to the CLUES study, a cohort with single-cell335
RNA-Seq data in eight peripheral blood mononuclear cell (PBMC) types from 234 individuals (see336
accompanying manuscript). We identified 1,025 and 1,223 genes with at least one shared and at337
least one cell-type-specific cis eQTL, respectively (hFDR≤ 5%). We extensively characterized these338
cell-type-specific eQTLs and showed that FastGxC cell-type-specific eQTLs for each cell type were339
significantly and specifically enriched for regions of chromatin accessibility in the same or closely340
related cell types (see accompanying manuscript).341
We next tested for enrichment of FastGxC shared and cell-type-specific eQTLs in sets of trait-342
associated variants from 59 immune-related traits in the GWAS catalog (Figure 7C). We compare343
these results to enrichment results from CxC eQTLs mapped in the same single-cell data set, as344
well as enrichment results from GTEx bulk CxC whole-blood and FastGxC whole-blood sp-eQTLs.345
Variants with cell-type-specific eQTL effects in the single-cell PBMC (scPBMC) data are enriched346
for disease-associated variants of nine immune-related traits (hFDR ≤ 5%). For example, variants347
with eQTL effects specific to conventional and plasmacytoid dendritic cells are enriched for allergic348
rhinitis-associated variants, consistent with the crucial role of dendritic cells in the development349
and maintenance of rhinitis [54]. In addition, variants with eQTL effects specific to B and CD4+350
T cells are enriched for rheumatoid arthritis-associated variants [26]. We observed a large overlap351
in the traits that were enriched for FastGxC and CxC mapped eQTLs, including the two examples352
highlighted above.353
The rapid adaptation of single-cell technologies in the past few years has provided an unprece-354
dented opportunity to dissect genetic regulatory mechanisms in granular cell types. In particular,355
we found that the allergy trait is enriched for single-cell eQTLs in plasmacytoid dendritic cells,356
celiac disease is enriched for natural killer cell-specific eQTLs, and chronic lymphocytic leukemia is357
enriched for eQTLs effects in and specific to several cell types (hFDR ≤ 5%). Critically, none of358
these trait enrichments were detected in the GTEx bulk data(hFDR ≤ 5%). We foresee that the359
increase in single-cell experiment sample sizes, which will necessarily come with decreasing materials360
and sequencing costs, will expand the ability of FastGxC to map single-cell context-specific eQTLs.361
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3 Discussion362
We developed FastGxC, a novel statistical method to efficiently and powerfully map context-specific363
eQTLs by leveraging the correlation structure of multi-context studies. We showed via simulations364
that FastGxC is as powerful as the state-of-the-art LMM-GxC method while orders of magnitude365
faster. We applied FastGxC to bulk multi-tissue and single-cell RNA-seq data sets and identified366
over 11 million tissue-specific and 280 thousand cell-type-specific eQTLs. Most context-specific367
effects manifest within loci with context-shared effects, highlighting the importance of defining368
context-specificity by effect size heterogeneity rather than the presence or absence of significant369
eQTL effects in each context. In addition, we found that tissue-specific eQTLs are shared mostly370
between groups of biologically related tissues and are more enriched in genomic elements that371
confer tissue specificity to gene expression, e.g., tissue-specific regions of open chromatin, providing372
further evidence of their validity. Finally, we found that context-specific eQTLs provide increased373
precision for identifying disease-relevant tissues across 138 complex traits, confirming their utility in374
understanding the context-specific gene regulatory mechanisms underlying complex human diseases.375
While FastGxC is the first efficient method to leverage intra-individual correlation for iden-376
tifying context-specific regulatory effects, several statistical methods using other techniques have377
been developed in recent years [4, 5, 32, 33, 55]. Most of these methods use matrix factorization378
of eQTL statistics to build data-driven priors that capture the underlying tissue-shared and tissue-379
specific architecture in eQTLs across tissues [4, 5, 55]. These flexible priors provide a considerable380
increase in power to map (context-specific) eQTLs compare to CxC eQTL mapping. However, they381
require extensive tuning of model hyper-parameters, making them computationally challenging for382
multi-context studies and complicating the interpretation of sharing and specificity of eQTLs across383
contexts. Interestingly, these methods are complementary to FastGxC as FastGxC output integrates384
naturally with these methods. The joint approaches may further increase the statistical power to385
map context-specific eQTLs as well as bypass the need for post hoc use of arbitrary cutoffs. Another386
recent work [9], use tests for interactions with inferred cell type proportion to identify interaction387
QTLs (iQTLs). This approach may also benefit from modelling intra-individual correlation, but388
can not be integrated with FastGxC directly as it requires a different mixed model.389
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FastGxC has several limitations. First, as done in previous work [3], we select the most390
relevant tissues for disease using experts in the field. However, the complete set of causal tissues391
is unknown, and rankings may change as we discover novel biology for each trait. Second, while392
the global test for context-specific eQTLs is always well-defined, the marginal tests for identify393
the contexts driving this heterogeneity are not, e.g., when every pair of contexts shows eQTL394
heterogeneity. However, we find that the marginal tests work well in practice, especially when only395
a few contexts drive this heterogeneity [4]. Third, FastGxC is limited to continuous phenotypes396
and discrete contexts. While there are natural LMM to apply outside of these situations, they397
are computationally inefficient. However, recent work in approximate algorithms may produce a398
solution [56]. Fourth, the current FastGxC method uses a decomposition with a single component399
shared across all contexts. It is straightforward to extend FastGxC when additional sharing exists400
across a subset of contexts, e.g., brain tissues in GTEx, by performing a hierarchical decomposition.401
Fifth, we define context-specificity as deviations of eQTL effects in each context from the effect in402
the average context. When, instead, deviations from the eQTL effect in a baseline context are of403
interest, e.g., when studying eQTL effects across time or differentiation states, it is straightforward404
to modify the decomposition step of FastGxC appropriately. Finally, relating context-specific eQTLs405
to GWAS variants is imperfect due to LD. Multi-context genomic colocalization approaches may406
improve the resolution of causal variants [57].407
In conclusion, we show that accounting for the intra-individual correlation and extensive shar-408
ing of eQTLs across contexts reveals context-specific eQTLs that can aid downstream interpretation409
of disease-associated variants. Moreover, we demonstrate the advantage of defining context speci-410
ficity by the heterogeneity of effect sizes rather than heuristic definitions based on subjective P-value411
thresholds. In the coming years, we believe that the application of FastGxC in the increasing num-412
ber of multi-context bulk and single-cell RNA-Seq studies holds enormous potential to broaden413
our understanding of the context-specific gene regulatory mechanisms underlying complex human414
diseases.415
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Figure 1. The FastGxC method and examples of sp-eQTLs. A. Overview of FastGxC
method. FastGxC decomposes the gene expression of an individual into a context-shared and
context-specific components (step 1) and estimates both the shared eQTL (sh-eQTL) effect across
contexts and context-specific eQTL effects in each context by regressing the genotypes on each of
these components (step 2). B. Toy examples of examples of sp-eQTLs. Y axis represents simulated
gene expression levels, x axis lists the genotypes of a candidate eQTL, color indicates tissue. The first
example corresponds to a scenario with no eQTLs in any tissue and, thus, no sh-eQTL or sp-eQTLs.
The second example illustrates a scenario with equal eQTL effects in all tissues, corresponding to a
scenario with a sh-eQTL but no sp-eQTLs in any tissue. The third and forth example corresponds
to scenarios with both sh-eQTL and sp-eQTL effects in which a single context (blood) or multiple
contexts drive the effect size heterogeneity.
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Figure 2. FastGxC outperforms existing methods in simulated data. A. Global type I
error rate of all methods under different amounts of intra-individual correlation. Both LMM-GxC
and FastGxC maintain proper type I error rate regardless of the intra-individual correlation while the
CxC and LM-GxC approaches become more conservative with increasing amount of intra-individual
correlation. B. Global power of all methods under the single-context heterogeneity scenario (Figure
1B). FastGxC is as powerful as the LMM-GxC approach with power increasing as a function of the
amount of intra-individual correlation for both methods. The CxC and LM-GxC approaches lose
power in the presence of intra-individual correlation. C. Marginal power of FastGxC to identify the
(most) heterogeneous context under the single-context heterogeneity scenario. D. Run time for all
methods for varying number of tests performed in a sample size of 250 individuals. See Figure S3D
for sample size of 1000 individuals. Last points reflect projected run time for entire GTEx data-set
- 50 contexts, 25K x 3M tests, and 250 samples per context. Analyses were run on 8 cores on a 2.70
GHz Intel Xeon Gold Processor on the UCLA Hoffman2 Computing Cluster.
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Figure 3. Tissue-specific eQTL mapping in GTEx.A. Correlation of PCs from tissue ex-
pression, tissue-shared expression, and tissue-specific expression with covariates related to study
design and sample quality in GTEx. The decomposition removes the intra-individual correlation as
demonstrated by lack of correlation between PCs from the tissue-specific expression and variables
that are shared/invariant within an individual across tissues, e.g. genotype PCs (gPC), sex, age,
etc. B. Number of sh-eQTLs and sp-eQTLs in each tissue. Point size reflects number of samples
for each tissue. C. Sharing and specificity of sp-eQTLs across tissues. Top: Number of tissues with
sp-eQTL effects. Bottom: Number of single tissue sp-eQTLs per tissue. D. Percent of eQTLs with
sp-only, sh-only, and both sp- and sh- (“both”) effects across all tissues. The majority of eQTLs
have only shared effects and most sp-eQTLs manifest within the shared effect loci.
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Figure 4. Tissue-specific eQTL effect sizes are correlated only between groups of
closely-related tissues. Pearson correlation of eQTL effect sizes across tissues. Right: FastGxC
sp-eQTL effect sizes are highly correlated only across related tissues. Largest cluster after hier-
archical clustering contains brain tissues, while remaining clusters are of roughly equal size and
contain tissues from related organ systems, i.e. integumentary, cardiovascular, digestive, etc. Left:
CxC eQTL effect sizes are highly correlated across both groups of biologically-related and unrelated
tissues. Largest cluster after hierarchical clustering on the CxC correlation matrix contains tissues
from the cardiovascular and digestive systems.
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Figure 5. FastGxC sp-eQTL variants are enriched in functional genomic features from
their respective tissues. A. Enrichment of variants with only sp-eQTL versus only sh-eQTL
FastGxE effects (left) and only FastGxC eQTL (sh- or sp- eQTLs) versus only CxC eQTL effects
(right) in genomic elements with known regulatory effects. B-C. Enrichment of single-tissue
eQTLs in ATAC-seq peaks from ENCODE (B) and TF binding sites [47] (C). Boxes indicate manual
matching between ENCODE ATAC-seq or TF footprint tissues and GTEx tissues. Circle indicates
statistically significant enrichment. FastGxC single-tissue sp-eQTLs are more often enriched for
the correct tissue and exhibit stronger enrichment than their CxC counterparts. TF: transcription
factor.
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Figure 6. Examples of eQTLs identified in GTEx. Each dot shows the effect size estimates
from CxC (L) and FastGxC (R) for a single tissue (color). A. An eQTL for the gene CBS shows
widespread sharing across GTEx tissues captured as 48 significant CxC eQTL effects. FastGxC
maps this genetic effect as a single sh-eQTL. B. An eQTL for the gene SIGLEC14 shows extensive
sharing across GTEx tissues captured as 47 significant CxC eQTL effects with similar effect sizes.
However, after modeling the sharing as a sh-eQTL, FastGxC also maps a sp-eQTL in whole blood,
consistent with the known role of SIGLEC14 in the immune system. C. An eQTL for the gene
LDHC, which acts primarily in testis, exhibits a strong positive effect in all tissues except the testis
for which the eQTL effect is in the opposite direction. This lone testis-specific effect becomes very
apparent when we examine sp-eQTLs with FastGxC.
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Figure 7. FastGxC identifies context-relevant mechanisms of complex traits. A. Ac-
curacy of FastGxC and CxC eQTLs to prioritize the most relevant tissue(s) across 138 complex
traits with a strong prior indication for the likely relevant tissue(s). B. Tissues prioritized by
FastGxC and CxC as well as the rank of the known relevant tissues for specific complex traits. C.
Enrichment of FastGxC shared and cell-type-specific eQTLs and CxC eQTLs mapped in each cell
type (x-axis) for a set of trait-associated variants from 59 immune-related traits in the NHGRI-
EBI GWAS catalog. For comparison, we include enrichment results from GTEx CxC whole blood
eQTLs and FastGxC whole-blood-specific eQTLs. Each dot represents the enrichment p-value and
the size represents the log2 odds ratio (OR) of a significant cell type-trait enrichment.
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Online Methods436
Relationship between FatsGxC, CxC, and LM(M)-GxC parameters. Let βc be the CxC437
eQTL effect in context c, as estimated by fitting a linear regression model per context, i.e., Eic =438
αc + βcGi + εic. Then, the CxC eQTL effect in context c is equal to the sum of the shared and439
context-c-specific eQTL effects from FastGxC, i.e. βc = β
sh + βcsc . In addition, let βref be the440
eQTL effect in an arbitrarily defined reference tissue and δc be the interaction eQTL effects for441
the non-reference tissues c from an L(M)M model with a genotype-by-context interaction term,442




c=2 δcGi × Kic + εic. Then, βref = βsh + βcsref and443
δc = βc − βref = βsh + βcsc − βsh − βcsref = βcsc − βcsref for c 6= ref . Full details of the analytical444
derivation are provided in the Supplementary Text.445
GTEx data. Fully processed, filtered, and normalized gene expression matrices (in BED format)446
for each tissue as well as covariates which were used as input for eQTL analysis were downloaded447
through the GTEx portal (https://www.gtexportal.org/home/datasets) on March 11, 2020.448
Gene expression matrices were residualized for covariates. WGS genotype VCF data were down-449
loaded from dbGap (dbGaP Accession phs000424.v8.p2). Only individuals with both genotype and450
gene expression data were kept. VCF files were processed with vcftools (v0.1.16) to keep only bi-451
allelic SNPs. Only variants with minor allele frequencies of greater than five percent in the tissue452
of interest were kept. Bcftools (v1.12) was used to annotate the genotype files with rs IDs. Plink453
(v1.90) was used to transpose and convert the vcf files to a sample x genotype matrix which was454
used as input for eQTL mapping.455
FastGxC and CxC eQTL mapping in GTEx and CLUES. Expression of each gene was456
centered to have mean zero across all individuals and tissues and decomposed into 49 tissue-specific457
expression components and one shared expression component using FastGxC. Cis genetic effects on458
the shared gene expression levels, each tissue-specific gene expression levels (FastGxC), and gene459
expression levels in each tissue (CxC) were estimated using ultra-fast implementations of simple460
linear regression models as implemented in the MatrixEQTL R package [31] with model=modelLINEAR461
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and 1e6 basepair distance for calling cis-eQTLs. Multiple testing correction was performed using462
the hierarchical FDR procedures implemented in the R package TreeQTL [58] with genes in level one,463
genes-tissues in level two, and genes-tissues-SNPs in level three. eQTL mapping in the single-cell464
CLUES data is described in detail here (see accompanying manuscript). Multiple testing correction465
was performed using hierarchical FDR with genes in level one, genes-cell-types in level two, and466
genes-cell-types-SNPs in level three.467
Correlation between PCs and covariates in GTEx The correlation between expression PCs468
and covariates in GTEx was computed using the canCorPairs function from the variancePartition469
R package ([59]). In short, when comparing two continuous variables (e.g. gPC1 or weight), Pear-470
son correlation was used. In order to accommodate the correlation between a continuous and a471
categorical variable (e.g. cohort) canonical correlation analysis (CCA) was used. Note that CCA472
returns correlations values between 0 and 1.473
Background SNP-gene pairs for enrichment analyses For all enrichment analysis, the474
matchit function from the MatchIt R package was used to match a set of background SNP-gene475
pairs to each variant set of interest by minor allele frequency (MAF) using the nearest neighbor476
matching method and a 1:1 matching ratio [60]. For eQTL sets that contained more than 5000477
variants, sets were randomly split into chunks to speed up computation.478
EQTL enrichment in genomic features Sp-eQTL only and sh-eQTL only variant sets were479
obtained by taking the set difference of sp-eQTL and sh-eQTL variants in R, respectively. The480
FastGxC eQTL variant set was obtained by taking the union of sh- and sp-eQTL variants across481
tissues. The CxC eQTL variant set was obtained by taking the union of eQTL variants across482
tissues. The set difference of FastGxC eQTL variant set and the CxC eQTL variants were then483
computed by taking the set difference in R to obtain the final FastGxC-only and CxC-only eQTL484
variant sets. All variants that were used as input into MatrixEQTL were inputted into the Ensembl485
Variant Effect Predictor (VEP) tool, which determines the effects of variants such as consequence486
on protein sequence or location within genomic regulatory elements. Enrichment analysis was487
then performed using the EQTL sets as described above and the VEP annotated variants list by488
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performing a Fisher’s exact test from the R stats package followed by a Benjamini and Hochberg489
multiple testing adjustment. Significance was called for BH-adjusted p-values less than 0.05.490
Enrichment in ENCODE ATAC-seq data All available tissue ATAC-seq data in the ”not per-491
turbed”, GRCh38, and bigBed narrowPeak categories were downloaded from www.encodeproject.492
org on Novemeber 2020. The downloaded bigBed files were converted to bed files for downstream493
analysis by the UCSC bigbedtobed tool. Bed files were then sorted using the bedtools sort -k1,1494
-k2,2n command to enable a memory-efficient algorithm for downstream intersections. Enrichment495
analysis of FastGxC and CxC single-tissue eQTL variants was then performed by intersecting each496
eQTL variant set of interest with each pre-sorted bed file, corresponding to ATAC-seq peaks from497
one tissue/sample, using the bedtools intersectBed command. Finally, Fisher’s exact test was used498
to obtain the statistical significance of each enrichment, followed by a Benjamini and Hochberg499
multiple testing adjustment. Significance was called for BH-adjusted p values less than 0.05.500
Enrichment in Transcription factor binding sites Transcription factor binding site data501
was downloaded on October 2020 from http://data.nemoarchive.org/other/grant/sament/502
sament/footprint_atlas/bed/ using the HINT algorithm and 16 basepair seed length. To con-503
strain analysis to the top footprints, the data was filtered using a HINT score greater than 200, as504
described by the method authors as an ideal threshold for high quality footprints [47]. TF footprint505
genomic intervals were sorted using the bedtools sort command as described above. Finally, enrich-506
ment of eQTL variant sets were performed by intersecting variants with TF footprints of each tissue507
using the bedtools intersectBed command. Fisher’s exact test was used to obtain the statistical508
significance of each enrichment, followed by a Benjamini and Hochberg multiple testing adjustment.509
Significance was called for BH-adjusted p values less than 0.05.510
Enrichment in GWAS loci Genome-wide association study (GWAS) data (gwas catalog v1.0.2-511
associations e100 r2020-06-17) was downloaded and processed from the NHGRI-EBI GWAS Catalog512
in August 2020 [53]. Matching of variants with and without eQTL effects was performed as described513
above. Only mapped traits within the GWAS catalog that contained more than ten variants were514
included in our downstream workflow. Enrichment analysis of FastGxC and CxC eQTL variants515
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was then performed by intersecting each eQTL variant set of interest with variants from each516
mapped trait by rs ID. Finally, Fisher’s exact test was used to obtain the statistical significance517
of each enrichment. A hierarchical multiple testing procedure was performed by first obtaining518
Simes’s method for combining p-value per tissue across mapped traits, BH-adjusting the resulting519
49 tissue-level p-values, and then retaining only tissues with BH-adjusted Simes’ p-values under520
the tissue-level α of 0.05. Then, within each significant tissue, p-values across all mapped traits521
were BH-adjusted and filtered using a trait-level α, i.e. tissue-level α * (n significant tissues /522
n total tissues) to obtain the final significant tissue-trait associations.523
Precision and recall of context-relevant mechanisms of complex traits. We manually524
annotated 138 traits within the GWAS Catalog with their most likely tissue of interest and used525
this annotation to assign precision and recall rates. More specifically, we used a contingency table,526
per trait, by calculating how often the trait of interest is both enriched in a tissue’s eQTLs and527
the tissue is the assigned likely-relevant tissue, giving true/false positive/negative rates (TP, FP,528
TN, FN). Finally, the precision score was calculated as TP / (TP + FP), and the recall score was529
calculated as TP / (TP + FN).530
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Supplementary Material531
Exact relation between FastGxC and CxC estimates532
Fix a gene and assume that its expression in each context follows a linear model:533
E0i, = Gβ
0 + εi, ∈ RC534
535
where:536
• E0 ∈ RN×C is the matrix of gene expression across N samples and C contexts, e.g. tissues or537
cell types538
• G ∈ RN×S is an arbitrary covariate matrix containing S features (in this paper, the features539
are cis-SNPs, and usually S = 1)540
• β0 ∈ RS×C are the context-specific effects captures arbitrarily distributed noise, assumed i.i.d.541
over samples i542
• εi, ∈ RC captures arbitrarily distributed noise, assumed i.i.d. over samples i but with covari-543
ance between contexts given by V (εi,) = Σ544
Now define the context-centered expression as:545
Ei = E
0
i − Ēi1TC or Eic = E0ic − Ēi546
547
where 1C ∈ RC is a vector of 1s and Ē ∈ RN is a vector containing each sample’s mean expression548
across all C contexts.549
For any arbitrary vector X ∈ R1×N , we have:550
XE = XE0 −XĒ1TC551
552
In particular, when X = 1‖Gj‖2Gj for SNP j, then:553
• XE := β̂ gives the FastGxC cs-eQTL effect size estimates for SNP j554
• XE0 := β̂0 gives the ordinary cs-eQTL effects555
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted June 18, 2021. ; https://doi.org/10.1101/2021.06.17.448889doi: bioRxiv preprint 
2
• XĒ := β̄ gives the FastGxC sh-eQTL effects556
Putting these three facts together proves:557
β̂c = β̂
0
c − β̄ or FastGxC = CxC− Shared558
559
for all contexts c. In words, the standard contest-specific estimates in CxC naturally and exactly560
decouple into the FastGxC estimates and the cross-context average estimate.561
By the same argument, CxC decomposes into FastGxC and shared effects even when:562
• Covariates are included, via X = 1‖P⊥Z Gj‖2GjP
⊥
Z , where P
⊥
Z is the orthogonal projection onto563
the span of the covariate matrix Z564
• Multiple SNP effects are fit simultaneously, via X = (GGT )−1GT565
• Ridge regression/kinship-based LMMs are used, if the regularization/heritability is equal566
across contexts567
Conceptually, associativity guarantees that linear operators applied to the left of the matrix E568
play well with linear operators applied to its right. And most regression involve linear operations on569
E from the left, while the centering operation used by GxC is a linear operator from the right. That570
is, we can center and then perform regressions (as in FastGxC) or can perform regular regressions571
and then center; these operations associate, therefore give identical results.572
Approximate relation between FastGxC and CxC standard errors573
Above, we showed the CxC estimates exactly decouple into FastGxC and shared estimates. Here,574
we show a similar result for the standard errors, though it holds only approximately. Specifically,575
the variance of the FastGxC estimate is roughly the variance of the CxC estimate minus the variance576
in the shared estimate. This provides a sharp description of the improvement in power in FastGxC577
over CxC due to removal of shared noise.578
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Loosely, the approximation assumes that the contexts are roughly exchangeable, or that each context585
is roughly equally correlated with other contexts1. For example, this holds exactly in the cases where586
contexts are IID (Σ = σ2I) or exchangeable (Σ = σ2I + bJ); conversely, this is violated if context587
c is very unique, or if there large and structured subsets of the contexts (eg brain regions).588
For example, imagine that C is large and that each sample’s noise has exchangeable dis-589
tribution across contexts, implying that V (εi,) = σ2I + sJ for some σ2 > c. Then the above590
approximation is exact, and standard error in FastGxC simply subtracts off the standard error for591













σ2 + s) ≈ 1
‖X‖2
σ2593
1More formally, if we assume that εi are i.i.d. with cross-context covariance matrix Σ, then:
Cov(β̂0c , β̄) = Cov(XE
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Thus, (∗) assumes that Σc. ≈ Σ.., i.e. that context c is about as correlated with the average context as any other.
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Inter-context noise correlation does not affect FastGxC estimates594
Say that samples are i.i.d. Gaussian but that contexts are correlated:595
Ei,
iid∼ Gi,β0 +N (0,Σ)596
597
Assume that we estimated or know the noise covariance Σ, e.g. with an LMM. The GLS and OLS598
estimates for B are identical–again, conceptually, the key fact is that column transformations on599
E operate independently of row transformations. (Σ acts on the rows of E, while G acts on the600
columns.) One way to see this is using the covariance across all entries of E, V (vec(E)) = Σ⊗ IN :601
β̂GLS :=
(
(G⊗ IP )T (IN ⊗ Σ)−1(G⊗ IP )
)−1
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Figure S1. Colors and abbreviations for GTEx tissues.
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Figure S2. Genetic correlation of gene expression across tissues in the GTEx study. Cis-
genetic and residual variance and covariance components for each gene-tissue pair across GTEx as
calculated using a linear mixed model with bivariate REML[61]. The gray units indicate tissue pairs
with less than 10% sample overlap. In both the genetic (upper) and residual (lower) components,
there was widespread correlation, and the brain tissues were relatively highly correlated compared
to other tissues.
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Figure S3. FastGxC performance in simulated data. (A) Marginal type I error rate for
FastGxC under different amounts of intra-individual correlation. FastGxC maintains proper type I
error rate for each context and different amounts of intra-individual correlation. (B) Global power
of each method to identify eQTL heterogeneity under the extensive heterogeneity scenario. (C)
Marginal power of FastGxC to identify the tissue(s) driving the eQTL effect size heterogeneity under
the extensive heterogeneity scenario. (D) Run time of each method in a simulated scenario with
1000 individuals. (E) Ability of FastGxC estimates under the null and two alternative scenarios to
estimate eQTL effects in each context.
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Figure S4. Comparison of FastGxC-only and CxC-only discoveries in GTEx. Comparing
discoveries that are mapped uniquely by each method, FastGxC discovers more eGenes, i.e. genes
with at least one sh- or sp-eQTL effects in at least one tissue, and eQTLs, i.e. gene-snp pairs with
sh- or sp-eQTL effects in at least one tissue, than CxC. FastGxC and CxC map roughly the same
number of eSNPs, i.e. variants with (sh- or sp-) eQTL effects in at least one tissue.
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Figure S5. Comparison of FastGxC sh- and sp- eQTLs. For each tissue, we plotted Venn
diagrams comparing the set of sp-eQTLs to sh-eQTLs. In the vast majority of tissues, sp-eQTLs
also have sh-eQTL effects. The distribution of sharing can be found in Figure 3D.
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Figure S6. Examples of eQTL mapped by FastGxC in GTEx. A. An eQTL for the gene
MUC20P1 and variant rs139637885 shows widespread sharing across all tissues except for LCLs.
This eQTL is captured by FastGxC as a sh-eQTL, as well as a sp-eQTL in LCLs and a less-obvious
sp-eQTL in thyroid. B. An eQTL for the gene GBP3. Another example of widespread sharing
that obscures a tissue-specific effect in the spleen. C. An eQTL for the gene GSTT2 and variant
rs369691 shows widespread sharing across all tissues in CxC. After the FastGxC procedure, two
sp-eQTLs emerge in the two skin tissues. D. Manhattan plot for LDHC eQTLs reveal a set of
variants with similar genetic effects as rs4757652. These eQTLs exhibit positive CxC genetic effects
across many tissues besides the testis, while the FastGxE procedure crystallizes this testis tissue
specificity.
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Table S1. FastGxC mapped GTEx sp-eGenes. FastGxC and CxC mapped sh- and sp-eGenes
from GTEx and CLUES cohorts are provided as a separate excel file, one sheet per study, with the
following columns: eGene type (CxC eGene, FastGxC sh-eGene, or FastGxC sp-eGene ), tissue or
cell type, gene identifier.
Table S2. EQTL enrichment in GWAS loci results. Results from enrichment of GTEx and
single-cell eQTLs from CxC and FastGxC in GWAS catalog loci are provided as a separate excel
file with two sheets. The first sheet shows manual annotation of most likely relevant tissue(s) for
GWAS catalog traits with the following columns: GWAS Trait, Most Likely Relevant Tissue(s).
The second sheet shows enrichment results with the following columns: GWAS trait, method, tissue
(GTEx) or cell type (single-cell), enrichment odds ratio (OR), OR lower confidence interval, OR
upper confidence interval, enrichment p-value.
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